Literature DB >> 28585802

Cu/Zn Superoxide Dismutase Forms Amyloid Fibrils under Near-Physiological Quiescent Conditions: The Roles of Disulfide Bonds and Effects of Denaturant.

M Ashhar I Khan1,2, Michal Respondek1, Sven Kjellström3, Shashank Deep2, Sara Linse3, Mikael Akke1.   

Abstract

Cu/Zn superoxide dismutase (SOD1) forms intracellular aggregates that are pathological indicators of amyotrophic lateral sclerosis. A large body of research indicates that the entry point to aggregate formation is a monomeric, metal-ion free (apo), and disulfide-reduced species. Fibril formation by SOD1 in vitro has typically been reported only for harsh solvent conditions or mechanical agitation. Here we show that monomeric apo-SOD1 in the disulfide-reduced state forms fibrillar aggregates under near-physiological quiescent conditions. Monomeric apo-SOD1 with an intact intramolecular disulfide bond is highly resistant to aggregation under the same conditions. A cysteine-free variant of SOD1 exhibits fibrillization behavior and fibril morphology identical to those of disulfide-reduced SOD1, firmly establishing that intermolecular disulfide bonds or intramolecular disulfide shuffling are not required for aggregation and fibril formation. The decreased lag time for fibril formation resulting from reduction of the intramolecular disulfide bond thus primarily reflects the decreased stability of the folded state relative to partially unfolded states, rather than an active role of free sulfhydryl groups in mediating aggregation. Addition of urea to increase the amount of fully unfolded SOD1 increases the lag time for fibril formation, indicating that the population of this species does not dominate over other factors in determining the onset of aggregation. Our results contrast with previous results obtained for agitated samples, in which case amyloid formation was accelerated by denaturant. We reconcile these observations by suggesting that denaturants destabilize monomeric and aggregated species to different extents and thus affect nucleation and growth.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; ThT fluorescence; disulfide reduction; protein aggregation; protein unfolding; transmission electron microscopy

Mesh:

Substances:

Year:  2017        PMID: 28585802     DOI: 10.1021/acschemneuro.7b00162

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  10 in total

1.  Network mapping of the conformational heterogeneity of SOD1 by deploying statistical cluster analysis of FTIR spectra.

Authors:  Sourav Chowdhury; Sagnik Sen; Amrita Banerjee; Vladimir N Uversky; Ujjwal Maulik; Krishnananda Chattopadhyay
Journal:  Cell Mol Life Sci       Date:  2019-04-22       Impact factor: 9.261

2.  Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis.

Authors:  Cheng Zhu; Matthew V Beck; Jack D Griffith; Mohanish Deshmukh; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

3.  Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS.

Authors:  Brianna Hnath; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2022-05-03       Impact factor: 3.699

4.  Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion.

Authors:  Li-Qiang Wang; Yeyang Ma; Han-Ye Yuan; Kun Zhao; Mu-Ya Zhang; Qiang Wang; Xi Huang; Wen-Chang Xu; Bin Dai; Jie Chen; Dan Li; Delin Zhang; Zhengzhi Wang; Liangyu Zou; Ping Yin; Cong Liu; Yi Liang
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

Review 5.  SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.

Authors:  Caterina Peggion; Valeria Scalcon; Maria Lina Massimino; Kelly Nies; Raffaele Lopreiato; Maria Pia Rigobello; Alessandro Bertoli
Journal:  Antioxidants (Basel)       Date:  2022-03-23

Review 6.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

7.  Revealing Well-Defined Soluble States during Amyloid Fibril Formation by Multilinear Analysis of NMR Diffusion Data.

Authors:  Kristine Steen Jensen; Sara Linse; Mathias Nilsson; Mikael Akke; Anders Malmendal
Journal:  J Am Chem Soc       Date:  2019-11-12       Impact factor: 15.419

8.  Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.

Authors:  Luke McAlary; Yee Lian Chew; Jeremy Stephen Lum; Nicholas John Geraghty; Justin John Yerbury; Neil R Cashman
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

9.  Influence of denaturants on amyloid β42 aggregation kinetics.

Authors:  Tanja Weiffert; Georg Meisl; Samo Curk; Risto Cukalevski; Anđela Šarić; Tuomas P J Knowles; Sara Linse
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

Review 10.  A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.

Authors:  E Srinivasan; R Rajasekaran
Journal:  J Mol Neurosci       Date:  2020-05-15       Impact factor: 3.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.